Fact CheckerSign in

NCT05332964Completed

Virtual Reliability System for Visual Spatial Attention Evaluation in Stroke Patients

Application of a Virtual Reliability System in the Evaluation of the Visual Spatial Attention in Stroke Patients

Source: ClinicalTrials.gov · Last updated 24 Feb 2026

Brief summary (registry, in English)

The researchers designed a software based on a head-mounted displays for virtual reality (HMD-VR) to evaluate the reaction time to stimuli presented at right or left visual field. The study will recruit 100 stroke patients with hemisphere lesions (50 patients for right and left each) and 100 age-matched healthy controls. The participants will conduct a simple reaction time task in VR, with stimuli designated in the left or right hemi-field. The stroke patients will also received traditional tests for hemi-neglect. Test-retest reliability of the assessment will be conducted in a subset of the control group. The stroke patients will be followed in 3-4 weeks.

Status (registry)
Completed
Study type
Observational
Enrollment
1 (actual)
First submitted
11 Apr 2022
Start date
1 Mar 2025
Primary completion date
31 Dec 2025
Lead sponsor
National Taiwan University Hospital
Diseases
Stroke
NCT number
NCT05332964

What you commit to

  • Study type: Observational
  • Participants enrolled: 1
  • From 1 Mar 2025 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • with history of neurological or psychiatric conditions other than stroke;
  • significant visual problems (such as color blindness, visual loss, cataract, glaucoma or other major eye condition)
  • upper limb musculoskeletal disorders to cause difficulties to use the keyboard or controller;
  • history of seizure, vestibular dysfunction or vertigo

Other

  • significant cognitive or speech problems that cause difficulties to cooperate with testing;
  • can't tolerate HMD-VR

Who the study is looking for

  • aged at least 20 years old
  • diagnosed with stroke involving unilateral MCA and ACA territory
  • with unilateral upper limb with normal function
  • neurologically and medically stable.
  • 1\) healthy adults, age-matched to stroke patients

Age in the registry: 20 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Taiwan University Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.